amfAR The Foundation for AIDS Research

03/26/2026

Early-career biomedical researchers—many of them women—get the critical funding they need to do breakthrough work through amfAR’s Krim Fellowship. The 2025 grantees—including Elizabeth Hastie, Tianling Ou, and Hannah King—are continuing the tradition of amfAR’s founding pioneers: Dr. Mathilde Krim and Elizabeth Taylor, who established amfAR to fund the science to end AIDS as a health threat. , ,

Donate today to help power their research, their careers, and the hope of a world without HIV.

https://amfar.donorsupport.co/page/FUNRGZNHEGZ?utm_source=I263AFIP###X&ms=I263AFIP###X&utm_medium=paid-social&utm_campaign=Women’s-history

03/25/2026

Get ready to bid on an extraordinary lineup of auction lots at ! This year’s selection features stunning artwork, one-of-a-kind experiences, and exclusive luxury items—all supporting amfAR’s lifesaving research.

Can’t attend in person? You can still place an absentee bid and make a meaningful impact: www.amfar.org/palmbeach.

Check out the lineup and be a part of this mission to transform global health.

• Graff — Carissa White Round and Pear Shape Diamond Earrings, over 12 cts

• Neil Jenney
“Improved Picasso, Mother and Child”, 2006. Oil on Canvas

• Oliver Clegg – Oil on canvas, Created exclusively for amfAR Palm Beach

• Jake Clark – Set of 3 earthenware vessels inspired by iconic Palm Beach (Carriage House, Colony Hotel, Le Bilboquet)

• Tierney Gearon Commission – an exclusive photo shoot at your location of choice, a print if your choosing, as well as a bespoke artist’s book of photographs from the session.

• SHA Advanced Longevity Escape – a 10 night stay at SHA Spain

• Exclusive amfAR Venezia Experience for Two – Five night stay at the San Clemente Palace and tickets to amfAR Venezia in September 2026

, , , , , ,

03/24/2026

Thrilled to announce that Grammy Award-nominated and multi-platinum pop powerhouse Zara Larsson will take the stage at on Thursday, May 21, 2026. Join us for an unforgettable evening in support of amfAR’s lifesaving research. Visit https://www.amfar.org/cannes for details.

03/24/2026

Thrilled to announce that Grammy Award-nominated and multi-platinum pop powerhouse will take the stage at on Thursday, May 21. Join us for an unforgettable evening in support of amfAR’s lifesaving research. Visit amfar.org/cannes for details.

03/24/2026

"There's an obligation to ensure that we stay focused on finding a cure, but there's a broader story. When you invest in HIV research, you're investing in a whole range of other diseases and chronic illnesses. Innovations exist in cancer treatment, in cellular immunology and vaccine development all because of HIV and researchers trying to understand this incredibly complicated virus. So for us, it’s broader than HIV. It's about truly advancing scientific discovery."

A Q&A with Kyle Clifford, the first H.I.V. positive CEO of AIDS research organization amfAR.

03/19/2026

We’re proud to announce the amfAR Research Council (aRC), an advisory group that will guide strategic direction of future amfAR-funded research. The nine-member panel will ensure all funded work can inform, strengthen, or accelerate HIV cure strategies. Its membership boasts two Nobel laureates and experts in a range of fields, including HIV, aging, neuroscience, cancer biology, and autoimmunity. https://www.amfar.org/press-releases/amfar-announces-formation-of-research-council-to-guide-future-research-investments/

03/18/2026

If you believe in advancing scientific discovery, if someone in your household takes a pill every day for either an illness or a chronic condition, by supporting amfAR, not only are you going to help us find a cure for HIV, but you’re actually supporting a whole series of researchers across the world that are working on really complicated issues related to what you could be yourself dealing with.” Listen to CEO Kyle Clifford’s interview on amfAR’s impact on the Business of Giving here: https://denver-frederick.com/2026/03/18/the-ceo-who-is-the-mission-kyle-clifford-of-amfar/

03/13/2026

Women (assigned female at birth) are underrepresented when it comes to PrEP users. Among all U.S. PrEP users in 2024, only 9% were women despite accounting for almost 1 in 5 new HIV diagnosis.

PrEP has many advantages. PrEP greatly reduces the risk of getting HIV for women who are sexually active (though it does not protect against other STIs). It has also been shown to lower HIV risk for injection drug users. The prevention option can be independently controlled. PrEP does not interfere with birth control methods. While trying to get pregnant, during pregnancy, or while breastfeeding, PrEP has been shown to protect women and their babies from getting HIV.

Please note that not all PrEP medications have been FDA-approved for women.

Learn more about HIV prevention at amfAR The Foundation for AIDS Research.org.

Source: AIDSvu

03/04/2026

Our 2025 Impact Report is out now!

Each HIV cure grant awarded by amfAR holds great potential—to develop strategies to eradicate HIV from the body or control the virus long-term without the use of antiretrovirals, and ultimately end AIDS once and for all.

In 2025, amfAR-funded researchers made two significant advances toward curing HIV using cutting-edge mRNA technology and an innovative combination of therapies.

In 2026, we will continue to fund breakthrough science and accelerate scientific discovery to help the 40M+ people living with HIV and others challenged by pressing health threats.

Read more about the accomplishments amfAR has achieved thanks to your support at amfar.org/impact

03/02/2026

Applications are now open for amfAR’s 2026 Target Grants, and key deadlines are approaching.

We’re looking for bold, hypothesis-driven HIV cure strategies that are clinically relevant, scalable, and designed to reach the communities most impacted by HIV.

📆 Informational webinar: TOMORROW, March 3 at 2 p.m. ET
📆 Synopsis deadline: March 10
📆 Full applications due: April 30 at 3 p.m. ET

If your work is ready to move the field forward, we encourage you to apply.

Learn more through the link in our bio.

02/28/2026

In the U.S., almost all children with HIV in this age range have acquired HIV via perinatal (mother-to-child) transmission, when HIV passes from the mother to a fetus or baby during pregnancy, labor and delivery, or breastfeeding. Early testing and treatment, among other strategies, can prevent perinatal transmission. In fact, the rate of perinatal transmission in the U.S. and Europe has been reduced to 1 percent or less.

Learn more about HIV prevention resources at amfar.org.